那么，如果不通过对手们所热衷的合并，他计划如何拯救阿斯特捷利康呢？

So how does he plan to save AstraZeneca, if not through the merger mania now intoxicating his rivals?

youdao

在去年英国基准指标富时100指数股票中，阿斯特捷利康是表现最好的股票之一。

Its shares were among the best-performing in Britain's benchmark FTSE 100 index last year.

youdao

投行公司荷兰国际集团（ING）在一项新报告中警告，由于阿斯特捷利康公司畅销药物的专利权将在未来几年中过期，公司将冒险进入“知识产权崩溃期”。

A new report from ING, an investment bank, warns that as the patents on AstraZeneca’s blockbusters expire in the coming years the firm risks going into “intellectual property meltdown”.

youdao